Share
CNBC Pro

Gritstone Oncology CEO on developing second generation Covid-19 vaccine

Gritstone Oncology CEO Andrew Allen joined Jim Cramer on "Mad Money" to explain the company's agreement with the National Institute for Allergy and Infectious Diseases to start testing a new vaccine for emerging coronavirus variants.
07:41
Wed, Jan 20 20217:19 PM EST

watch now
VIDEO07:00
CNBC ProTom Lee: This is an opportunity to add more cyclical exposure
watch now
VIDEO09:01
CNBC ProWhy AlphaOne's Dan Niles only likes this tech stock
watch now
VIDEO04:07
CNBC ProWhere Dan Suzuki says investors should put money amid recovery
watch now
VIDEO46:45
CNBC ProWatch Thursday's full episode of the Halftime Report
watch now
VIDEO05:11
CNBC ProSome markets look vulnerable to valuation compression if inflation rises: Strategist